Pylera and Cervicitis - a phase IV clinical study of FDA data
Summary:
We study 1,754 people who take Pylera (bismuth subcitrate potassium; metronidazole; tetracycline) or have Cervicitis. No report of Cervicitis is found in people who take Pylera.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Pylera?
Pylera has active ingredients of bismuth subcitrate potassium; metronidazole; tetracycline. eHealthMe is studying from 1,036 Pylera users. Check the latest studies of Pylera.
What is Cervicitis?
Cervicitis (inflammation of the uterine cervix) is found to be associated with 149 drugs and 265 conditions by eHealthMe. Check the latest studies of Cervicitis.
No report is found.
Do you take Pylera and have Cervicitis?
- Check whether Cervicitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Pylera:
- Pylera (1,036 reports)
Cervicitis treatments and more:
- Cervicitis (718 reports)
How severe was Cervicitis and when was it recovered:
Expand to all the drugs that have ingredients of bismuth subcitrate potassium; metronidazole; tetracycline:
Browse all side effects of Pylera:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cervicitis:
Browse all the conditions that are associated with Cervicitis:
How the study uses the data?
The study uses data from the FDA. It is based on bismuth subcitrate potassium; metronidazole; tetracycline (the active ingredients of Pylera) and Pylera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Rasilez and Glyburide - 5 seconds ago
- Drug interactions of Nicotine Polacrilex and Lomotil - 6 seconds ago
- Drug interactions of Meloxicam and Travatan - 12 seconds ago
- Drug interactions of Reglan and Nubain - 20 seconds ago
- Could Coreg cause Hallucination, Visual? - 22 seconds ago
- Could Sulfasalazine cause Fever? - 23 seconds ago
- Could Zofran cause Dehydration? - 24 seconds ago
- Drug interactions of Pegasys and Xalatan - 28 seconds ago
- Could Solu-Medrol cause Drug Intolerance? - 32 seconds ago
- Could Xtandi cause Fainting? - 32 seconds ago